TerminatedPhase 4

PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)

Stopped: Number of eligible patients too small.

Germany12 participantsStarted 2008-11

Plain-language summary

Examination of CRT efficacy in patients with progressive heart failure and atrial fibrillation at the same time

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * LVEF \<35% * QRS time ≥150ms LBB * NYHA classification ≥ NYHA III * permanent (\> 6 months) Atrial Fibrillation * sinus rhythm (control group) * Condition after Implantation of a Medtronic CRT device * written informed consent Exclusion Criteria: * exchange of the current CRT device * mitral incompetence (2. degree) * no compliance * participation in another study * pregnancy * patients with AV node * patients after heart transplant or those who are on the transplant list

What they're measuring

End systolic left ventricular diameter

Timeframe: 12 months

Trial details

NCT IDNCT00839566

SponsorMedtronic Cardiac Rhythm and Heart Failure

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2012-03

View on ClinicalTrials.gov More Atrial Fibrillation trials